Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Vano YA, Elaidi R, Bennamoun M, Chevreau C, Borchiellini D, Pannier D, Maillet D, Gross-Goupil M, Tournigand C, Laguerre B, Barthélémy P, Coquan E, Gravis G, Houede N, Cancel M, Huillard O, Beuzeboc P, Fournier L, Méjean A, Cathelineau X, Doumerc N, Paparel P, Bernhard JC, de la Taille A, Bensalah K, Tricard T, Waeckel T, Pignot G, Braychenko E, Caruso S, Sun CM, Verkarre V, Lacroix G, Moreira M, Meylan M, Bougouïn A, Phan L, Thibault-Carpentier C, Zucman-Rossi J, Fridman WH, Sautès-Fridman C, Oudard S. Vano YA, et al. Among authors: fridman wh. Lancet Oncol. 2022 May;23(5):612-624. doi: 10.1016/S1470-2045(22)00128-0. Epub 2022 Apr 4. Lancet Oncol. 2022. PMID: 35390339 Clinical Trial.
Fc gamma receptors.
Cohen-Solal JF, Cassard L, Fridman WH, Sautès-Fridman C. Cohen-Solal JF, et al. Among authors: fridman wh. Immunol Lett. 2004 Apr 15;92(3):199-205. doi: 10.1016/j.imlet.2004.01.012. Immunol Lett. 2004. PMID: 15081612 Review. No abstract available.
Fc gamma receptors and cancer.
Cassard L, Cohen-Solal J, Camilleri-Broët S, Fournier E, Fridman WH, Sautès-Fridman C. Cassard L, et al. Among authors: fridman wh. Springer Semin Immunopathol. 2006 Dec;28(4):321-8. doi: 10.1007/s00281-006-0058-8. Epub 2006 Nov 10. Springer Semin Immunopathol. 2006. PMID: 17096153 Review.
Characterization of immune functions in TRAF4-deficient mice.
Cherfils-Vicini J, Vingert B, Varin A, Tartour E, Fridman WH, Sautès-Fridman C, Régnier CH, Cremer I. Cherfils-Vicini J, et al. Among authors: fridman wh. Immunology. 2008 Aug;124(4):562-74. doi: 10.1111/j.1365-2567.2008.02810.x. Epub 2008 Feb 18. Immunology. 2008. PMID: 18284467 Free PMC article.
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.
Adotevi O, Pere H, Ravel P, Haicheur N, Badoual C, Merillon N, Medioni J, Peyrard S, Roncelin S, Verkarre V, Mejean A, Fridman WH, Oudard S, Tartour E. Adotevi O, et al. Among authors: fridman wh. J Immunother. 2010 Nov-Dec;33(9):991-8. doi: 10.1097/CJI.0b013e3181f4c208. J Immunother. 2010. PMID: 20948437 Clinical Trial.
The immune microenvironments of lung and intraocular tumors.
Sautès-Fridman C, Dieu-Nosjean MC, Damotte D, Fisson S, Fridman WH. Sautès-Fridman C, et al. Among authors: fridman wh. Bull Cancer. 2011 Jun;98(6):58-61. doi: 10.1684/bdc.2011.1374. Bull Cancer. 2011. PMID: 21616749 Free article.
536 results